BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1423010)

  • 1. Comparison of the release of vasoactive factors from venous and arterial bovine cultured endothelial cells.
    D'Orleans-Juste P; Mitchell JA; Wood EG; Hecker M; Vane JR
    Can J Physiol Pharmacol; 1992 May; 70(5):687-94. PubMed ID: 1423010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture.
    White DG; Mundin JW; Sumner MJ; Watts IS
    Br J Pharmacol; 1993 Aug; 109(4):1128-32. PubMed ID: 8401924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium-derived relaxing factor.
    Baydoun AR; Woodward B
    Br J Pharmacol; 1991 Jul; 103(3):1829-33. PubMed ID: 1657268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells.
    Lückhoff A; Pohl U; Mülsch A; Busse R
    Br J Pharmacol; 1988 Sep; 95(1):189-96. PubMed ID: 3064851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
    Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
    Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of bovine endothelial thromboxane receptors triggers release of prostacyclin but not EDRF.
    Clesham G; Parsaee H; Joseph S; McEwan JR; MacDermot J
    Cardiovasc Res; 1992 May; 26(5):513-7. PubMed ID: 1446322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells.
    Parsaee H; McEwan JR; Joseph S; MacDermot J
    Br J Pharmacol; 1992 Dec; 107(4):1013-9. PubMed ID: 1361398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
    Crack P; Cocks T
    Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell.
    Johns RA; Peach MJ; Linden J; Tichotsky A
    Circ Res; 1990 Oct; 67(4):979-85. PubMed ID: 2170053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
    Thiemermann C; Mustafa M; Mester PA; Mitchell JA; Hecker M; Vane JR
    Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinins act on B1 or B2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells.
    D'Orléans-Juste P; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Apr; 96(4):920-6. PubMed ID: 2545298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular mechanism of endothelin-induced nitric oxide synthesis by cultured bovine endothelial cells.
    Hirata Y; Emori T
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S225-8. PubMed ID: 7509951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of prostacyclin, endothelium-derived relaxing factor and endothelin by freshly harvested cells attached to microcarrier beads.
    Kibira S; Dudek R; Narayan KS; Bing RJ
    Mol Cell Biochem; 1991 Nov; 108(1):75-84. PubMed ID: 1663210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
    Kuhn M; Otten A; Frölich JC; Förstermann U
    J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.
    Hecker M; Mitchell JA; Harris HJ; Katsura M; Thiemermann C; Vane JR
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1037-43. PubMed ID: 2322257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of captopril on the bradykinin-induced release of prostacyclin from guinea-pig lungs and bovine aortic endothelial cells.
    de Nucci G; Warner T; Vane JR
    Br J Pharmacol; 1988 Nov; 95(3):783-8. PubMed ID: 2850062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin-induced release of PGI2 from aortic endothelial cell lines: responses mediated selectively by Ca2+ ions or a staurosporine-sensitive kinase.
    Parsaee H; McEwan JR; MacDermot J
    Br J Pharmacol; 1993 Sep; 110(1):411-5. PubMed ID: 8220902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.